LARGO, Fla., June 20 /PRNewswire-FirstCall/ -- GeoPharma, Inc. stated today that it will file its Form-10KSB and announce its earnings for the fiscal year ended March 31, 2006 on June 29, 2006. Due to international travel schedules, the Company will host a conference call on Thursday, July 6, 2006 at 11:30 a.m. (EDT) with CEO Mihir Taneja and VP/CFO Carol Dore-Falcone. A separate release will follow with the conference call dial in number and related participant passcodes.
GeoPharma, Inc. is a rapidly growing pharmaceutical company specializing in the manufacturing and distribution of over-the-counter, nutritional, generic drug and functional food products. The company’s growth strategy is to capitalize on its manufacturing expertise to develop high margin generic or novel drugs for niche markets with high barriers to entry. GeoPharma’s competitive advantage lies in its ability to circumvent or overcome the challenges in these markets. For more about GeoPharma, Inc., go to our websites at http://www.geopharmainc.com , http://www.onlineihp.com and http://www.carbslim.com .
This press release may contain statements, which constitute forward- looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those regarding the company and its subsidiaries’ expectations, intentions, strategies and beliefs pertaining to future performance. All statements contained herein are based upon information available to the company’s management as of the date hereof, and actual results may vary based upon future events, both within and without management’s control. Important factors that could cause such differences are described in the company’s periodic filings with the Securities and Exchange Commission.
GeoPharma, Inc.
CONTACT: Carol Dore-Falcone, VP-CFO, GeoPharma, Inc., +1-727-544-8866,ext. 244, or cdf@onlineihp.com
